ASX - By Stock
|
AVH |
Re:
Media
|
|
saltland
|
236 |
87K |
26 |
13/07/23 |
13/07/23 |
ASX - By Stock
|
236
|
87K
|
26
|
|
ASX - By Stock
|
AVH |
Re:
The near term future
|
|
saltland
|
144 |
56K |
3 |
13/07/23 |
13/07/23 |
ASX - By Stock
|
144
|
56K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
The near term future
|
|
saltland
|
144 |
56K |
6 |
13/07/23 |
13/07/23 |
ASX - By Stock
|
144
|
56K
|
6
|
|
ASX - By Stock
|
AVH |
Re:
The near term future
|
|
saltland
|
144 |
56K |
8 |
13/07/23 |
13/07/23 |
ASX - By Stock
|
144
|
56K
|
8
|
|
ASX - By Stock
|
AVH |
Re:
The near term future
|
|
saltland
|
144 |
56K |
7 |
12/07/23 |
12/07/23 |
ASX - By Stock
|
144
|
56K
|
7
|
|
ASX - By Stock
|
AVH |
Re:
The near term future
|
|
saltland
|
144 |
56K |
1 |
09/07/23 |
09/07/23 |
ASX - By Stock
|
144
|
56K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
The near term future
|
|
saltland
|
144 |
56K |
4 |
09/07/23 |
09/07/23 |
ASX - By Stock
|
144
|
56K
|
4
|
|
ASX - By Stock
|
AVH |
Re:
The near term future
|
|
saltland
|
144 |
56K |
7 |
08/07/23 |
08/07/23 |
ASX - By Stock
|
144
|
56K
|
7
|
|
ASX - By Stock
|
AVH |
Re:
The near term future
|
|
saltland
|
144 |
56K |
5 |
01/07/23 |
01/07/23 |
ASX - By Stock
|
144
|
56K
|
5
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Receives FDA Approval for Full-Thickness Skin
|
|
saltland
|
127 |
42K |
4 |
27/06/23 |
27/06/23 |
ASX - By Stock
|
127
|
42K
|
4
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Announces FDA Approval of RECELL for Vitiligo
|
|
saltland
|
116 |
36K |
7 |
25/06/23 |
25/06/23 |
ASX - By Stock
|
116
|
36K
|
7
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Announces FDA Approval of RECELL for Vitiligo
|
|
saltland
|
116 |
36K |
8 |
24/06/23 |
24/06/23 |
ASX - By Stock
|
116
|
36K
|
8
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Announces FDA Approval of RECELL for Vitiligo
|
|
saltland
|
116 |
36K |
7 |
24/06/23 |
24/06/23 |
ASX - By Stock
|
116
|
36K
|
7
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Announces FDA Approval of RECELL for Vitiligo
|
|
saltland
|
116 |
36K |
12 |
23/06/23 |
23/06/23 |
ASX - By Stock
|
116
|
36K
|
12
|
|
ASX - By Stock
|
AVH |
Re:
SP if both FDA approvals go through
|
|
saltland
|
233 |
83K |
2 |
19/06/23 |
19/06/23 |
ASX - By Stock
|
233
|
83K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
SP if both FDA approvals go through
|
|
saltland
|
233 |
83K |
14 |
18/06/23 |
18/06/23 |
ASX - By Stock
|
233
|
83K
|
14
|
|
ASX - By Stock
|
AVH |
Re:
SP if both FDA approvals go through
|
|
saltland
|
233 |
83K |
8 |
17/06/23 |
17/06/23 |
ASX - By Stock
|
233
|
83K
|
8
|
|
ASX - By Stock
|
AVH |
Re:
SP if both FDA approvals go through
|
|
saltland
|
233 |
83K |
6 |
17/06/23 |
17/06/23 |
ASX - By Stock
|
233
|
83K
|
6
|
|
ASX - By Stock
|
AVH |
Re:
SP if both FDA approvals go through
|
|
saltland
|
233 |
83K |
11 |
17/06/23 |
17/06/23 |
ASX - By Stock
|
233
|
83K
|
11
|
|
ASX - By Stock
|
AVH |
Re:
SP if both FDA approvals go through
|
|
saltland
|
233 |
83K |
5 |
17/06/23 |
17/06/23 |
ASX - By Stock
|
233
|
83K
|
5
|
|
ASX - By Stock
|
AVH |
Re:
SP if both FDA approvals go through
|
|
saltland
|
233 |
83K |
4 |
16/06/23 |
16/06/23 |
ASX - By Stock
|
233
|
83K
|
4
|
|
ASX - By Stock
|
AVH |
Re:
SP if both FDA approvals go through
|
|
saltland
|
233 |
83K |
6 |
15/06/23 |
15/06/23 |
ASX - By Stock
|
233
|
83K
|
6
|
|
ASX - By Stock
|
AVH |
Re:
SP if both FDA approvals go through
|
|
saltland
|
233 |
83K |
12 |
15/06/23 |
15/06/23 |
ASX - By Stock
|
233
|
83K
|
12
|
|
ASX - By Stock
|
AVH |
Re:
Media
|
|
saltland
|
236 |
87K |
1 |
10/06/23 |
10/06/23 |
ASX - By Stock
|
236
|
87K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
Media
|
|
saltland
|
236 |
87K |
14 |
10/06/23 |
10/06/23 |
ASX - By Stock
|
236
|
87K
|
14
|
|
ASX - By Stock
|
OCC |
Re:
Ann: John Van Der Wielen appointed Independent Non-Exec Chair
|
|
saltland
|
10 |
3.8K |
4 |
29/05/23 |
29/05/23 |
ASX - By Stock
|
10
|
3.8K
|
4
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Q1 2023 Investor Presentation
|
|
saltland
|
117 |
38K |
5 |
27/05/23 |
27/05/23 |
ASX - By Stock
|
117
|
38K
|
5
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Q1 2023 Investor Presentation
|
|
saltland
|
117 |
38K |
8 |
27/05/23 |
27/05/23 |
ASX - By Stock
|
117
|
38K
|
8
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Q1 2023 Investor Presentation
|
|
saltland
|
117 |
38K |
6 |
27/05/23 |
27/05/23 |
ASX - By Stock
|
117
|
38K
|
6
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Q1 2023 Investor Presentation
|
|
saltland
|
117 |
38K |
1 |
27/05/23 |
27/05/23 |
ASX - By Stock
|
117
|
38K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Q1 2023 Investor Presentation
|
|
saltland
|
117 |
38K |
6 |
27/05/23 |
27/05/23 |
ASX - By Stock
|
117
|
38K
|
6
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Q1 2023 Investor Presentation
|
|
saltland
|
117 |
38K |
13 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
117
|
38K
|
13
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Q1 2023 Investor Presentation
|
|
saltland
|
117 |
38K |
2 |
22/05/23 |
22/05/23 |
ASX - By Stock
|
117
|
38K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Q1 2023 Investor Presentation
|
|
saltland
|
117 |
38K |
2 |
22/05/23 |
22/05/23 |
ASX - By Stock
|
117
|
38K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Q1 2023 Investor Presentation
|
|
saltland
|
117 |
38K |
20 |
21/05/23 |
21/05/23 |
ASX - By Stock
|
117
|
38K
|
20
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Q1 2023 Investor Presentation
|
|
saltland
|
117 |
38K |
3 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
117
|
38K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Q1 2023 Investor Presentation
|
|
saltland
|
117 |
38K |
3 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
117
|
38K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Q1 2023 Investor Presentation
|
|
saltland
|
117 |
38K |
5 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
117
|
38K
|
5
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Q1 2023 Investor Presentation
|
|
saltland
|
117 |
38K |
8 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
117
|
38K
|
8
|
|
ASX - By Stock
|
AVH |
Re:
FN Arena article has a good summary
|
|
saltland
|
8 |
2.1K |
0 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
8
|
2.1K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Quarterly Financial Report Form 10-Q
|
|
saltland
|
97 |
31K |
3 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
97
|
31K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
FN Arena article has a good summary
|
|
saltland
|
8 |
2.1K |
2 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
8
|
2.1K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Q1 2023 Investor Presentation
|
|
saltland
|
117 |
38K |
1 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
117
|
38K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Q1 2023 Investor Presentation
|
|
saltland
|
117 |
38K |
3 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
117
|
38K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Q1 2023 Investor Presentation
|
|
saltland
|
117 |
38K |
7 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
117
|
38K
|
7
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Q1 2023 Investor Presentation
|
|
saltland
|
117 |
38K |
1 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
117
|
38K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
AVH Chart
|
|
saltland
|
711 |
263K |
8 |
16/05/23 |
16/05/23 |
ASX - By Stock
|
711
|
263K
|
8
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Quarterly Financial Report Form 10-Q
|
|
saltland
|
97 |
31K |
7 |
15/05/23 |
15/05/23 |
ASX - By Stock
|
97
|
31K
|
7
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical to Announce First Quarter 2023 Results
|
|
saltland
|
70 |
23K |
0 |
15/05/23 |
15/05/23 |
ASX - By Stock
|
70
|
23K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical to Announce First Quarter 2023 Results
|
|
saltland
|
70 |
23K |
5 |
15/05/23 |
15/05/23 |
ASX - By Stock
|
70
|
23K
|
5
|
|